1. Home
  2. MTDR vs ALKS Comparison

MTDR vs ALKS Comparison

Compare MTDR & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MTDR

Matador Resources Company

HOLD

Current Price

$52.81

Market Cap

6.3B

Sector

Energy

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$51.94

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTDR
ALKS
Founded
2003
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
7.5B
IPO Year
2011
2012

Fundamental Metrics

Financial Performance
Metric
MTDR
ALKS
Price
$52.81
$51.94
Analyst Decision
Buy
Buy
Analyst Count
15
14
Target Price
$63.07
$43.43
AVG Volume (30 Days)
1.7M
2.3M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,696,277,000.00
$1,475,899,000.00
Revenue This Year
$7.15
$24.26
Revenue Next Year
$7.63
$4.47
P/E Ratio
N/A
N/A
Revenue Growth
5.46
N/A
52 Week Low
$37.14
$25.17
52 Week High
$66.84
$55.67

Technical Indicators

Market Signals
Indicator
MTDR
ALKS
Relative Strength Index (RSI) 52.02 60.77
Support Level $52.34 $27.78
Resistance Level $57.65 $55.67
Average True Range (ATR) 1.45 1.98
MACD 0.53 -0.58
Stochastic Oscillator 76.15 35.07

Price Performance

Historical Comparison
MTDR
ALKS

About MTDR Matador Resources Company

Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream. The company generates majority of its revenue from the exploration and production segment.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: